Long‐term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo‐controlled studies

Những quyển sách tương tự

• Certolizumab pegol for the treatment of patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trials
  Bằng: Blauvelt, A., et al.
  Được phát hành: (2018)
• Long‐term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3‐year results from two randomized phase III trials (CIMPASI‐1 and CIMPASI‐2)
  Bằng: Gordon, K.B., et al.
  Được phát hành: (2020)
• Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: 52-Week Results
  Bằng: Umezawa, Yoshinori, et al.
  Được phát hành: (2021)
• A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis
  Bằng: Gottlieb, AB, et al.
  Được phát hành: (2012)
• Certolizumab pegol
  Bằng: Goel, Niti, et al.
  Được phát hành: (2010)